Divergent roles for p55 and p75 tumor necrosis factor receptors in the pathogenesis of MOG35-55-induced experimental autoimmune encephalomyelitis

被引:123
作者
Suvannavejh, GC
Lee, HO
Padilla, J
Dal Canto, MC
Barrett, TA
Miller, SD
机构
[1] Northwestern Univ, Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA
[2] Northwestern Univ, Sch Med, Dept Med, Chicago, IL 60611 USA
[3] Northwestern Univ, Sch Med, Dept Pathol, Chicago, IL 60611 USA
[4] Northwestern Univ, Sch Med, Interdepartmental Immunobiol Ctr, Chicago, IL 60611 USA
关键词
TNF; TNF receptor; p55; p75; EAE; MS; CNS; autoimmunity; inflammation; regulation;
D O I
10.1006/cimm.2000.1706
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
To clarify the role of tumor necrosis factor (TNF) in the inflammatory aspects of autoimmunity vs its potential role in the apoptotic elimination of autoreactive effector cells, we assessed the roles of the p55 (TNFR1/Tnfrsf1a/CD120a) and p75 (TNFR2/ Tnfrsf1b/CD120b) TNF receptors in the pathogenesis of MOG(35-55)-induced experimental autoimmune encephalomyelitis (EAE). TNFR p55/p75(-/-) double knockout mice were completely resistant to clinical disease. TNFR p55(-/-) single knockout mice were also totally resistant to EAE, exhibiting reduced MOG(35.55)(..) specific proliferative responses and Th1 cytokine production, despite displaying equivalent DTH responses. Importantly, IL-5 was significantly increased in p55-/- mice. In contrast, p75(-/-) knockout mice exhibited exacerbated EAE, enhanced Th1 cytokine production, and enhanced CD4(+) and F4/80(+) CNS infiltration. Thus, p55/TNFR1 is required for the initiation of pathologic disease, whereas p75/ TNFR2 may be important in regulating the immune response. These results have important implications for therapies targeting p55 and p75 receptors for treatingautoimmune diseases. (C) 2000 Academic Press.
引用
收藏
页码:24 / 33
页数:10
相关论文
共 64 条
  • [1] Akassoglou K, 1997, J IMMUNOL, V158, P438
  • [2] Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice - Models for multiple sclerosis with primary oligodendrogliopathy
    Akassoglou, K
    Bauer, J
    Kassiotis, G
    Pasparakis, M
    Lassmann, H
    Kollias, G
    Probert, L
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (03) : 801 - 813
  • [3] [Anonymous], 1999, Neurology, V53, P457
  • [4] INHIBITION OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS BY AN ANTIBODY TO THE INTERCELLULAR-ADHESION MOLECULE ICAM-1
    ARCHELOS, JJ
    JUNG, S
    MAURER, M
    SCHMIED, M
    LASSMANN, H
    TAMATANI, T
    MIYASAKA, M
    TOYKA, KV
    HARTUNG, HP
    [J]. ANNALS OF NEUROLOGY, 1993, 34 (02) : 145 - 154
  • [5] Low-molecular-weight tumor necrosis factor receptor p55 controls induction of autoimmune heart disease
    Bachmaier, K
    Pummerer, C
    Kozieradzki, I
    Pfeffer, K
    Mak, TW
    Neu, N
    Penninger, JM
    [J]. CIRCULATION, 1997, 95 (03) : 655 - 661
  • [6] Impairment of TNF-receptor-1 signaling but not Fas signaling diminishes T-cell apoptosis in myelin oligodendrocyte glycoprotein peptide-induced chronic demyelinating autoimmune encephalomyelitis in mice
    Bachmann, R
    Eugster, HP
    Frei, K
    Fontana, A
    Lassmann, H
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (05) : 1417 - 1422
  • [7] Barone C M, 1993, J Craniofac Surg, V4, P177, DOI 10.1097/00001665-199307000-00013
  • [8] Begolka WS, 1998, J IMMUNOL, V161, P4437
  • [9] IDENTIFICATION OF 2 TYPES OF TUMOR-NECROSIS-FACTOR RECEPTORS ON HUMAN CELL-LINES BY MONOCLONAL-ANTIBODIES
    BROCKHAUS, M
    SCHOENFELD, HJ
    SCHLAEGER, EJ
    HUNZIKER, W
    LESSLAUER, W
    LOETSCHER, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (08) : 3127 - 3131
  • [10] BROWN A, 1982, LAB INVEST, V46, P171